https://9krapalm.com/dualitybio-announces-china-nmpa-acceptance-of-biologics-license-application-seeking-approval-for-trastuzumab-pamirtecan-for-the-treatment-of-unresectable-or-metastatic-her2-positive-adult-breast-cance/ เสิร์ฟข่าวไอที อัปเดตเทคโนโลยีสไตล์ @krapalm Thu, 09 Apr 2026 13:11:51 +0000 hourly 1 https://wordpress.org/?v=7.0